z-logo
open-access-imgOpen Access
eP187: Decentralization of clinical trials in the era of COVID-19: Implications for rare disease trials
Author(s) -
Kriti Manjrekar,
Mary C. Freeman,
Karli Hedstrom,
Luca Fierro,
Hetanshi Naik,
George A. Díaz,
Manisha Balwani,
Jaya Ganesh
Publication year - 2022
Publication title -
genetics in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.509
H-Index - 128
eISSN - 1530-0366
pISSN - 1098-3600
DOI - 10.1016/j.gim.2022.01.223
Subject(s) - covid-19 , clinical trial , disease , decentralization , medicine , rare disease , intensive care medicine , virology , political science , outbreak , infectious disease (medical specialty) , law

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom